304
Participants
Start Date
November 30, 2013
Primary Completion Date
February 28, 2015
Study Completion Date
February 28, 2015
Topical IBU twice daily
Topical gel administered as 4 inch strip twice daily for 7 days, and as needed for an additional 3 days
Placebo twice daily
Topical gel administered as a 4 inch strip twice daily for 7 days, and as needed for an additional 3 days
Topical IBU three times daily
Topical gel administered as a 4 inch strip three times daily for 7 days, and as needed for additional 3 days
Placebo three times daily
Topical gel administered as a 4 inch strip three times daily for 7 days, and as needed for additional 3 days
Danville Orthopedic Clinic, Danville
PMG Research of Salisbury, Salisbury
Sunrise Research Institute, Inc., Miami
Doctors Research Network, South Miami
L&L Research Choices, Miami
Helen Keller Hospital, Sheffield
Lillestol Research, LLC, Fargo
Quality Clinical Research, Inc., Omaha
Heartland Clinical Research, Inc., Omaha
MedPharmics, LLC, Metairie
Clinical Trial Network, Houston
Clinical Trials of Texas, Inc., San Antonio
Clinical Trials of Texas, San Antonio
Sports Medicine Associates of San Antonio, San Antonio
Elite Clinical Trials LLLP, Blackfoot
Visions Clinical Research - Tucson, Tucson
eStudy Site, San Diego
San Diego Sports Medicine and Family Health Center, San Diego
Orange County Research Institute, Anaheim
Lead Sponsor
Pfizer
INDUSTRY